PBI31 COST-EFFECTIVENESS COMPARISON OF RISANKIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF SEVERE PSORIASIS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.135
https://www.valueinhealthjournal.com/article/S1098-3015(19)32513-6/fulltext
Title :
PBI31 COST-EFFECTIVENESS COMPARISON OF RISANKIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF SEVERE PSORIASIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32513-6&doi=10.1016/j.jval.2019.09.135
First page :
Section Title :
Open access? :
No
Section Order :
10093